In addition to commercial development, Haleigh’s role will also encompass thought leadership, strategy development, and supporting all functional areas within the organization. Prior to joining Uprise Health, Haleigh has held the position of Chief Commercial Officer at Brightline as well as Chief Revenue Officer at Collective Health.
“I am thrilled to be joining such an amazing team at Uprise,” said Haleigh. “I’m looking forward to helping increase awareness of the broad suite of tech-enabled mental health and chronic condition support solutions the organization has built. As I learned more about the company, I was really impressed by how Uprise Health has used technology to increase utilization and improve effectiveness of their EAP product, while also providing services to support higher acuity needs.”
About Uprise Health Uprise Health is an all-in-one mental health and employee wellbeing solution. By offering members greater access to care coupled with industry-leading technology and proactive outreach to at-risk members, utilization of Uprise Health is drastically higher than traditional EAPs. Members report lower stress and anxiety while organizations reduce risk of turnover, drastically improve productivity, and save money on healthcare costs. Through a vast network of clinical experts and providers across the United States, Uprise Health has been delivering services for over 30 years to millions of members representing a diverse group of employers, health plans, and partners.
“Our collaboration with RxCKSTxR perfectly reflects why we’re dedicated to treating dogs and cats like family. They make our lives great.” says Dan Pingree, Chief Marketing Officer at PetMeds®. “It’s when we truly listen to them that we understand their needs – and hilarity ensues when we realize that our pets are just like us.”
“Dogs and cats have a lot to say, which is why it’s been an honor to team up with PetMeds, a company that shares our passion for giving pets a voice.” says Bobby “RxCKSTxR” Johnson. “When we treat dogs and cats like family, they don’t hesitate to let us know how they really feel.”
About PetMeds® Founded in 1996, PetMeds® (petmeds.com) is Your Trusted Pet Health Expert, providing fast, easy and helpful service to over 10 million customers across the U.S. by delivering prescription and non-prescription medications and pet supplies for less, direct to the consumer through its PetMeds® toll-free number, on the Internet through its website PetMeds.com, or with the PetMeds® mobile app available for free at Google Play for Android and the App Store for iOS. PetCareRx (petcarerx.com) is a wholly owned subsidiary of PetMeds®, whose mission is to add love to the world by enhancing the lives of pets and pet parents.
About RxCKSTxR Founded in 2020, RxCKSTxR is an ensemble of comedy voiceover actors led by rapper and producer Bobby Johnson. In 2023, the team has been in the works of producing a full-length animated feature film titled “Birdy and Pooch.” RxCKSTxR’s viral voiceover videos can be found at @theRxCKstXR on TikTok and Instagram. For more information about RxCKSTxR’s upcoming projects, visit ih8rxckstxr.com.
Approximately 80% of rare diseases are estimated to have a genetic origin.(4) Dysmorphology is a clinical genetics discipline that studies and interprets patterns of human growth and structural defects, encompassing malformation, disruption, deformation, and dysplasia.(5) “Phenotype” pertains to the observable physical properties of an organism, including its appearance, development, and behavior.(6) AI can analyze and interpret this visible data (e.g., from photos or images) to quickly detect physical markers that may indicate the pathology of certain rare diseases.
Around 40% of rare diseases show craniofacial changes aiding early diagnosis, such as in the eyebrows, nose, and cheeks. Previously, visual evaluation and basic measurements were used, but now AI can provide even more objective methods. However, AI algorithms mostly rely on European and North American databases, overlooking global diversity.(7)
An advanced AI system, such as “GestaltMatcher,” can utilize and link facial traits and features with clinical symptoms and genetic data, serving as a starting point for accurate diagnoses with high precision. It requires fewer patients for feature matching, a significant advantage for ultra-rare diseases with limited cases worldwide. Doctors will soon be able to use AI on smartphones for differential diagnoses, complementing their expertise.(8)
AI/ML algorithms efficiently analyze genetic datasets, swiftly identifying disease-causing variants without requiring time-consuming manual interpretation. By incorporating diverse data sources and human genomic expertise, these AI systems learn to predict candidate variants for undiagnosed genetic disorders, providing valuable insights to genetics and precision medicine researchers. This revolutionary approach enables experts to make rapid, precise, and groundbreaking diagnoses, not only of known disease-causing variants but also aid in the discovery of novel causal variants, ultimately improving patient outcomes.(9)
Genomic studies have predominantly utilized samples from people of European ancestry, neglecting the opportunity to learn from larger and more genetically diverse populations, particularly in Asia, which comprises 59.5% of the world’s population. This exclusion impedes the equitable advancement of genomic medicine, leading to persistent uncertainty concerning the genetic basis and epidemiology of diseases across various populations and disparities in drug reactions, treatment outcomes, and overall health. Similarly, in immunogenomics research, a lack of diversity hinders the discovery of novel genetic traits associated with immune system phenotypes, both common and distinct across populations. The underrepresentation of non-Caucasian populations from genomics research, understanding how pathogens have applied selective pressures on immune-related genes in diverse environments, and the subsequent manifestation of infectious diseases remains incomplete.(10)
Dr. Rajasimha urges, “So much has already been accomplished with AI advancements and innovation. Intelligent technologies can cast a wider net for more diverse patient recruitment and facilitate the completion of global clinical trials. Inherent biases can be removed through better AI training with more inclusive and heterogeneous datasets. It’s worrisome that we are training far too many AI and ML models for rare disease research with biased datasets from only 10% of the world’s population residing in the global north, to begin with. Awareness plays a pivotal role in this, and all members along the research continuum share the responsibility to promote cross-cultural collaboration to help ensure the inclusion of all patients with rare and common diseases representative of all humans globally.”
The IndoUSrare Corporate Alliance unites biopharmaceutical, diagnostics, medical devices, CROs, and other life science companies to advance orphan product development. Their mission is to collaborate to address common challenges impacting the industry in the pre-competitive space to educate, empower, and advocate for rare disease patients in the United States, India, and globally. By fostering collaboration, global diversity, and pooling resources, the alliance aims to accelerate diagnostics and therapies and bridge critical gaps in affordable research and development through cross-border partnerships.
Join the conversation at the “Digitization of Rare Diseases” session at the upcoming Indo US Bridging RARE Summit 2023. Register Now! October 29–30, 2023.
On the evening of Sunday, October 29th, the summit will honor eminent leaders for fostering cross-border collaborations in rare diseases between the US and India at a Gala dinner at the Arlington, VA, campus of George Mason University.
About IndoUSrare
IndoUSrare is a humanitarian nonprofit 501(c)(3) tax-exempt public charity organization based in the United States. Founder and Executive Chairman Dr. Harsha Rajasimha, who lost a child to a rare disease in 2012, has been a rare disease advocate for more than 10 years. To address the unmet needs of diverse patients with rare diseases globally, the leadership team comprised of experienced professionals from research, advocacy, regulatory, and drug development seeks to build cross-border collaborations connecting stakeholders of rare diseases in low- and middle-income regions such as India, with their counterparts and clinical researchers in the United States to improve the diversity of clinical trial participants, accelerate research and development, and improve equitable access to life-saving therapies to diverse populations of rare disease patients. Visit https://indousrare.org.
References:‥
1. U.S. Department of Health and Human Services. (2023, March 21). Rare disease day at NIH 2023: Putting hope into action. National Center for Advancing Translational Sciences. ncats.nih.gov/pubs/features/rare-disease-day-at-NIH-2023-putting-hope-into-action#:~:text=Rare%20diseases%20are%20individually%20rare,nearly%20400%20million%20people%20worldwide. 2. Commissioner, O. of the. (n.d.). Rare diseases at FDA. U.S. Food and Drug Administration. fda.gov/patients/rare-diseases-fda. 3. Visibelli, A., Roncaglia, B., Spiga, O., Santucci, A. (2023, March 13). The impact of Artificial Intelligence in the Odyssey of rare diseases. MDPI. mdpi.com/2227-9059/11/3/887. 4. Frederiksen, S. D., Avramovi;#263;, V., Maroilley, T., Lehman, A., Arbour, L., Tarailo-Graovac, M. (2022, February 22). Rare disorders have many faces: In silico characterization of rare disorder Spectrum – Orphanet Journal of rare diseases. BioMed Central. ojrd.biomedcentral.com/articles/10.1186/s13023-022-02217-9#:~:text=Approximately%2080%25%20of%20rare%20diseases,to%20have%20a%20genetic%20origin. 5. Hunter, A. G. W. (2002, August 20). Medical genetics: 2. the diagnostic approach to the child with dysmorphic signs. CMAJ‥: Canadian Medical Association journal = journal de l’Association medicale canadienne. ncbi.nlm.nih.gov/pmc/articles/PMC117854/#:~:text=The%20term%20dysmorphic%20is%20derived,human%20growth%20and%20structural%20defects. 6. Nature Publishing Group. (n.d.). Nature news. nature.com/scitable/definition/phenotype-phenotypes-35/#:~:text=The%20term%20%22phenotype%22%20refers%20to,environmental%20influences%20upon%20these%20genes. 7. Henderson, R. by E. (2023, May 11). AI algorithms for rare disease diagnosis ignore the genetic, morphological diversity of humans. News. news-medical.net/news/20230510/AI-algorithms-for-rare-disease-diagnosis-ignore-the-genetic-morphological-diversity-of-humans.aspx. 8. Shawn, A. (2022, February 11). Researchers use artificial intelligence to detect rare diseases even more accurately – sciencedaily. Verve times. vervetimes.com/researchers-use-artificial-intelligence-to-detect-rare-diseases-even-more-accurately-sciencedaily/. 9. Contributor, E. (2022, December 13). Artificial Intelligence: A new era in rare genetic disease diagnosis. Labiotech.eu. labiotech.eu/opinion/rare-disease-diagnosis-ai/. 10. Peng, K., Safonova, Y., Shugay, M., Popejoy, A. B., Rodriguez, O. L., Breden, F., Brodin, P., Burkhardt, A. M., Bustamante, C., Cao-Lormeau, V.-M., Corcoran, M. M., Duffy, D., Fuentes-Guajardo, M., Fujita, R., Greiff, V., Jönsson, V. D., Liu, X., Quintana-Murci, L., Rossetti, M., … Mangul, S. (2021, May 17). Diversity in immunogenomics: The value and the Challenge. Nature News. nature.com/articles/s41592-021-01169-5.
GRAND BLANC, Mich., Sept. 4, 2023 /PRNewswire/ — ModuleMD, a leading healthcare technology and services company, announced today that it has acquired Diversified Health Care Management, Inc. (“Diversified”) and MedEase Practice Management software (DBA Professional Management Services,…
“The RecoveryNet app will help peer specialists accurately and efficiently track their work while providing accurate data to the organizations that employ them. Now more than ever, the peer support workforce needs trusted, reliable, and versatile tools and resources,” said Patty McCarthy, CEO of Faces & Voices of Recovery. “The digital age provides endless opportunities for networking and connections at our fingertips. Through this partnership with Elevance Health Foundation, we can help make this vision a reality.”
The RecoveryNet app will be deployed and integrated into Faces & Voices of Recovery’s data platform, a cloud-based data collection system focused on tracking and measuring recovery outcomes of individuals who are currently going through treatment. The app is also available for immediate download and usage on all Apple and Android devices.
“Through this partnership, we are furthering our promise to advance health equity for those who are impacted by a mental health or substance use disorder by increasing access to care via the RecoveryNet app,” said Shantanu Agrawal, M.D., Chief Health Officer of Elevance Health. ” One in three adults in the U.S. report having either a substance use disorder or a mental health issue in the past year, and 13.5% of young adults report having both a substance use disorder and mental illness. Substance use disorder continues to impact the health and wellbeing of communities across the country, which is why we’re committed to working with all stakeholders – particularly people with lived expertise – in developing solutions to improve whole health.”
The investment from Elevance Health Foundation is part of the organization’s larger commitment of $30 million over a three-year span to make significant progress improving the mental health and well-being in communities, with an emphasis on substance use disorders. To date, the Foundation has awarded more than $19.5 million in these programs.
To learn more about Faces & Voices of Recovery, visit here
ABOUT FACES & VOICES OF RECOVERY Faces & Voices of Recovery, located in Washington, D.C., is organizing the over 23 million Americans in recovery from addiction to alcohol and other drugs, their families, friends and allies in a campaign to end discrimination, broaden social understanding, and achieve a just response to addiction as a public health crisis. For more information, visit www.facesandvoicesofrecovery.org
ABOUT ELEVANCE HEALTH FOUNDATION Elevance Health Foundation is the philanthropic arm of Elevance Health, Inc. The Foundation works to advance health equity by focusing on improving the health of the socially vulnerable through partnerships and programs in our communities with an emphasis on maternal child health; substance use disorder; and food as medicine. Additionally, the Foundation also responds to disasters when our communities need us the most. Through its key areas of focus, the Foundation strategically aligns with Elevance Health’s focus on community health and becoming a lifetime, trusted health partner that is fueled by its purpose to improve the health of humanity. The Foundation coordinates with the company’s year-round Dollars for Dollars program which provides 100 percent match of associates’ donations, as well as its Volunteer Time Off and Dollars for Doers community service programs. To learn more about Elevance Health Foundation, please visit www.elevancehealth.foundation or follow us @ElevanceFND on Twitter and Elevance Health Foundation on Facebook.
TALLAHASSEE, Fla., Sept. 1, 2023 /PRNewswire/ — All Hands and Hearts (AHAH), a prominent disaster relief organization, has activated its Disaster Assistance Response Team (DART) to provide swift and comprehensive aid in the aftermath of Hurricane Idalia’s devastating impact on Florida….
This new academic partnership will host the first 13 pre-selected Bachelor of Science in Nursing (BSN) sophomore students to join AHS and focus on public service and the work of a safety net health care system.
Romoanetia Lofton, DNP, MSN, MBA, RN, NE-BC, system chief nursing officer and Wilma Chan Highland Hospital Campus chief administrative officer, is the AHS executive sponsor of the program.
“Alameda Health System is pleased to welcome USF’s Nurse Health Equity Scholars,” said Lofton. “AHS is a vanguard of medical excellence and a haven for the most vulnerable patient populations. It is an ideal learning environment for nursing students who are passionate about providing equitable, compassionate, and culturally sensitive care. Here, Nurse Health Equity Scholars will gain practical experience delivering on the AHS mission: Caring, Healing, Teaching, and Serving All.”
“I am honored to have developed this program focusing on health equity and supporting meeting culturally sensitive and specific nursing education demands,” Dr. Fry-Bowers stated. “Nursing is changing its focus from merely delivering health care to developing health and eliminating health inequities. It recognizes that nurses need to be equipped with the necessary skills to provide care tailored to the unique needs of different individuals and communities. Scholars will also have access to additional educational and professional development opportunities that will intentionally prepare them to work in the public safety net sector. We are excited to launch the Nurse Health Equity Scholars program and promote health equity and justice.”
About Alameda Health System
Alameda Health System (AHS) is a leading public integrated health care provider and medical training institution recognized for patient and family-centered care and reducing health disparities. AHS provides comprehensive medical treatment, behavioral health services, disease prevention and health promotion throughout our integrated network of hospitals, wellness centers and skilled nursing and rehabilitation facilities. AHS includes three acute care hospitals, a psychiatric hospital, four ambulatory care wellness centers, five post-acute facilities, and the only adult Level 1 Trauma Center and psychiatric emergency department in Alameda County. AHS is committed to eliminating health disparities, promoting wellness and improving the health of the community through its mission of caring, healing, teaching and serving all. For more information, visit AlamedaHealthSystem.org.
About the USF School of Nursing and Health Professions
The mission of the USF School of Nursing and Health Professions is to improve the health of all populations through equitable and compassionate service, value-driven research, and innovative education of health professionals, preparing them to use their hearts, minds, and souls to change the health of the world. For more information, visit our website.
About the University of San Francisco
The University of San Francisco is a private, Jesuit Catholic university that reflects the diversity, optimism, and opportunities of the city that surrounds it. USF offers more than 230 undergraduate, graduate, professional, and certificate programs in the arts and sciences, business, law, education, and nursing and health professions. At USF, each course is an intimate learning community in which top professors encourage students to turn learning into positive action, so the students graduate equipped to do well in the world — and inspired to change it for the better. For more information, visit usfca.edu.
Little Journey is on a mission to support all children to better health through personalized care. Each child is unique, with different needs, concerns and ways of thinking. The company also recognizes the profound impact that a child’s experience of care has on their long-term health behaviors; as such, Little Journey believes that every child’s healthcare journey should be tailored to their individual needs and the support provided unique to them. Discover how Little Journey co-created “A Little About Me” to leap beyond the typical medical history by focusing on the holistic well-being of the child and their unique needs.
As part of the LEGO Foundation: Play for All accelerator, Little Journey has spent the last year working to enhance its support for neurodiverse children and their families through use of Learning through Play and Design for all principles. Working alongside the National Association of Special Educational needs and an array of subject matter experts, Little Journey has created new approaches to co-creation and co-design with families to ensure the neurodiverse child’s voice is heard.
Attend this webinar to hear from several subject matter experts on how to unleash the power of play in healthcare and how we can enhance the connection between families and healthcare, especially for neurodiverse children.
Register for the live webinar on Friday, September 15, 2023, at 1pm EDT (10am PDT) featuring keynote speakers Maureen Dunne, Neurodiversity & Inclusion Expert, NSF Fellow, Women 2.0 Founder to Watch, Kauffman Fellow, Elected Official, Social Enterprise Execution, Board Director and YPO Member; and Rachel Callander, Artist & Author of Super Power Baby Project and Super Power Kids; along with Thomas Leth Frandsen, MD, PhD, Chief Medical Project Officer at Mary Elizabeth’s Hospital; Jamie Galpin, Developmental Psychologist and Specialist Consultant, Special Networks; Dorthe Feveile Kjerkegaard, Experienced Specialist and Project Lead, The LEGO Foundation; and Chris Evans, MBBS, PhD, CEO & Co-Founder, Little Journey. For more information, or to register for this event, visit Unleashing the Power of Play: Enhancing The Connection Between Families and Healthcare Organisations.
ABOUT XTALKS
Xtalks, powered by Honeycomb Worldwide Inc., is a leading provider of educational webinars to the global life science, food and medical device community. Every year, thousands of industry practitioners (from life science, food and medical device companies, private & academic research institutions, healthcare centers, etc.) turn to Xtalks for access to quality content. Xtalks helps Life Science professionals stay current with industry developments, trends and regulations. Xtalks webinars also provide perspectives on key issues from top industry thought leaders and service providers.
The Group’s Revenue Hits New Heights Net profit for 1H2023 increased more than 2.8 times YoY Benefited from the Full Resumption of Normal Travel Revenue Continues to Generate Profit in Future Results Highlights Since the full resumption of normal travel between Hong Kong, Macau and…
Distinguished as a premier mobile concierge service for vitamin and supplement IV infusions, The Wellness Lab takes a proactive and holistic stance on IV hydration. Merging the latest evidenced-based research with medical expertise, our team has meticulously designed a program rooted in prevention. Our paramount mission is to furnish personalized and safe “cocktails” of nutrients tailored to your individual needs. The convenience of our services shines as we bring the healing potential of these unique vitamin infusions directly to your doorstep. Whether you’re in Naples or any surrounding city, our IV Therapy services are at your disposal. In most instances, we guarantee arrival within two hours of your call, ensuring efficient and effective care. Let The Wellness Lab be your partner in achieving your wellness aspirations – because we’re dedicated to your well-being from the inside out.
Haute Beauty is affiliated with the luxury lifestyle publication Haute Living. As a section of Haute Living magazine, Haute Beauty covers the latest advancements in beauty and wellness, providing readers with expert advice on aesthetic and reconstructive treatments through its network of acclaimed doctors and beauty experts.
